ERCC1 and neoplasm: In a recent work, it was shown that the expression levels of ERCC1, TYMS, and TOP2α were significantly associated with clinical and pathological parameters: menopausal status, tumor size, lymph node metastasis, hormone receptor status, triple-negative status, Ki-67 index, and epidermal growth factor receptor [31].